Humana Inc. buy Guggenheim
Summary
This prediction ended on 10.04.26 with a price of €167.00. The BUY prediction by Guggenheim for Humana Inc. performed very badly with a performance of -36.02%. Guggenheim has a follow-up prediction for Humana Inc. where he still thinks Humana Inc. is a Buy. Guggenheim has 50% into this predictionHumana Inc. (Symbol: HUM) is a leading healthcare and wellness company headquartered in Louisville, Kentucky, specializing in offering a diversified range of health insurance, wellness programs, and managed care plans to individual, group, government, and military customers. With a strong commitment to providing personalized, affordable, and high-quality healthcare solutions, Humana emphasizes on simplifying access and meeting the evolving needs of its vast clientele through leveraging data analytics, technology, and innovation. As a publicly traded entity, Humana’s stock is listed on the New York Stock Exchange, and it forms part of the esteemed S&P 500 index, reflecting its significant impact and presence within the highly competitive healthcare sector.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Humana Inc. | 6.355% | 6.355% | -36.704% |
| iShares Core DAX® | 2.554% | -0.112% | 14.995% |
| iShares Nasdaq 100 | 2.742% | -0.470% | 30.954% |
| iShares Nikkei 225® | 6.584% | 3.221% | 49.697% |
| iShares S&P 500 | 1.930% | -0.519% | 24.883% |
Comments by Guggenheim for this prediction
In the thread Humana Inc. diskutieren
In the thread Trading Humana Inc.